Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

Affiliations

• ¹ Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
• ² Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
• ³ High Throughput Screening Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
• ⁴ Worldwide Influenza Centre, The Francis Crick Institute, London NW1 1AT, UK.
• ⁵ Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
• ⁶ Structural Biology Scientific Technology Platform, The Francis Crick Institute, London NW1 1AT, UK.
• ⁷ High Throughput Screening Laboratory, The Francis Crick Institute, London NW1 1AT, UK; University College London Hospitals NHS Foundation Trust Biomedical Research Centre, London, UK.
• ⁸ Cell Biology of Infection Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
• ⁹ Safety, Health & Sustainability, The Francis Crick Institute, London NW1 1AT, UK; University College London Cancer Institute, London, UK.
• ¹⁰ Scientific Computing Scientific Technology Platform, The Francis Crick Institute, London NW1 1AT, UK.
• ¹¹ Metabolomics Scientific Technology Platform, The Francis Crick Institute, London NW1 1AT, UK.
• ¹² Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London NW1 1AT, UK.
• ¹³ Department of Pathology, The Royal Marsden NHS Foundation Trust, London, UK; Translational Cancer Biochemistry Laboratory, Institute of Cancer Research, London, UK.
• ¹⁴ Department of Pathology, The Royal Marsden NHS Foundation Trust, London, UK.
• ¹⁵ Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK; Acute Oncology Service, The Royal Marsden NHS Foundation Trust, London, UK.
• ¹⁶ Anaesthetics, Perioperative Medicine and Pain Department, The Royal Marsden NHS Foundation Trust, London, UK.
• ¹⁷ Gastrointestinal Unit, The Royal Marsden NHS Foundation Trust, London, UK.
• ¹⁸ Clincal Oncology Unit, The Royal Marsden NHS Foundation Trust, London, UK.
• ¹⁹ Cell Biology of Infection Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Division of Medicine, University College London, London, UK.
• ²⁰ Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
• ²¹ Neurodegeneration Biology Laboratory, The Francis Crick Institute, London NW1 1AT, UK; UCL Queen Square Institute of Neurology, London, UK.
• ²² Structural Biology of Disease Processes Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
• ²³ RNA Virus Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
• ²⁴ Retroviral Immunology Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
• ²⁵ Haemato-oncology Unit, The Royal Marsden NHS Foundation Trust, London, UK.
• ²⁶ Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK; Melanoma and Kidney Cancer Team, Institute of Cancer Research, London, UK. Electronic address: samra.turajlic@crick.ac.uk.